You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
|
|---|---|
| Published in |
Lancet Oncology, September 2019
|
| DOI | 10.1016/s1470-2045(19)30569-8 |
| Pubmed ID | |
| Authors |
Douglas H Brand, Alison C Tree, Peter Ostler, Hans van der Voet, Andrew Loblaw, William Chu, Daniel Ford, Shaun Tolan, Suneil Jain, Alexander Martin, John Staffurth, Philip Camilleri, Kiran Kancherla, John Frew, Andrew Chan, Ian S Dayes, Daniel Henderson, Stephanie Brown, Clare Cruickshank, Stephanie Burnett, Aileen Duffton, Clare Griffin, Victoria Hinder, Kirsty Morrison, Olivia Naismith, Emma Hall, Nicholas van As, D Dodds, E Lartigau, S Patton, A Thompson, M Winkler, P Wells, T Lymberiou, D Saunders, M Vilarino-Varela, P Vavassis, T Tsakiridis, R Carlson, G Rodrigues, J Tanguay, S Iqbal, M Winkler, S Morgan, A Mihai, A Li, O Din, M Panades, R Wade, Y Rimmer, J Armstrong, M Panades, N Oommen |
X Demographics
The data shown below were collected from the profiles of 116 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 24 | 21% |
| United States | 20 | 17% |
| Spain | 8 | 7% |
| Australia | 5 | 4% |
| Germany | 4 | 3% |
| Canada | 4 | 3% |
| Ireland | 3 | 3% |
| France | 2 | 2% |
| Japan | 2 | 2% |
| Other | 12 | 10% |
| Unknown | 32 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 70 | 60% |
| Scientists | 28 | 24% |
| Practitioners (doctors, other healthcare professionals) | 18 | 16% |
Mendeley readers
The data shown below were compiled from readership statistics for 356 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 356 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 53 | 15% |
| Other | 46 | 13% |
| Student > Doctoral Student | 29 | 8% |
| Student > Ph. D. Student | 27 | 8% |
| Student > Bachelor | 21 | 6% |
| Other | 59 | 17% |
| Unknown | 121 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 139 | 39% |
| Physics and Astronomy | 13 | 4% |
| Nursing and Health Professions | 9 | 3% |
| Agricultural and Biological Sciences | 5 | 1% |
| Social Sciences | 5 | 1% |
| Other | 37 | 10% |
| Unknown | 148 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 915. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2023.
All research outputs
#19,013
of 25,837,817 outputs
Outputs from Lancet Oncology
#21
of 6,943 outputs
Outputs of similar age
#358
of 354,796 outputs
Outputs of similar age from Lancet Oncology
#2
of 123 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,943 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,796 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.